Explore >> Select a destination

You are here

 brighterworld.mcmaster.ca
Researchers to begin human trials for promising new inhaled COVID-19 vaccines designed to combat variants of concern - Brighter World
| | www.fda.gov
FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants | FDA
2.5 parsecs away

Travel
| | The FDA amended the emergency use authorization of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. The updated vaccine addresses currently circulating variants to provide better protection against serious consequences of COV
| | hub.jhu.edu
What will it take to develop a vaccine for COVID-19? | Hub
3.3 parsecs away

Travel
| | Global health expert Ruth Karron discusses the work currently taking place at laboratories around the country to develop a vaccine for COVID-19
| | news.mcmaster.ca
Researchers to begin human trials for promising new inhaled COVID-19 vaccines designed to combat variants of concern - McMaster News
0.0 parsecs away

Travel
| | Vaccines developed at McMaster target the lungs first. [...]Read More...
| | www.horsejournals.com
What is Salmonellosis in Horses? | Horse Journals
20.4 parsecs away

Travel
| Salmonellosis is a disease associated with the bacteria Salmonella enterica that causes diarrhea in horses and humans. It is usually seen sporadically but may become an epidemic depending on the virulence of the organism, level of exposure, and host factors.